Reports
Reports
Analyst Viewpoint
Rise in prevalence of coronary heart disease and growth in geriatric population are some of the key coronary artery bypass graft market drivers. Coronary artery bypass graft allows for the removal of fatty build-up and blockages in arteries through minimally invasive surgeries. Advancements in the surgical sector, including robotic surgeries, are fueling the demand for coronary artery bypass grafts, thereby augmenting market progress.
Growth in technological developments in the global healthcare sector, especially in developing countries, is likely to offer lucrative coronary artery bypass graft market opportunities to companies operating in the industry. Key players are investing substantially in the manufacture of polymer-based restorative devices for cardiovascular treatment. Thus, increase in investments in product development is a vital coronary artery bypass graft marketing strategy adopted by the leading companies.
Coronary artery bypass graft is a surgical procedure conducted for the treatment of heart diseases. The procedure increases blood flow and oxygen supply to the heart by diverting blood around clogged parts of the major arteries.
Coronary artery bypass surgery is performed to create a new path for blood flow to the heart. In this surgery, a healthy blood vessel from another body part is used to redirect blood around the blocked artery.
Adequate blood flow, lower risk of stroke, less possibility of respiratory diseases, and reduced chest pain and shortness of breath are some of the prominent advantages of the coronary artery bypass graft.
Single or multiple grafts are used in coronary surgeries depending on the number of blockages and severity of blood clotting in the arteries. These grafts are extensively employed during minimally invasive surgeries, as these surgeries entail fewer incisions and require less time to operate.
Coronary heart diseases are caused by blocked or interrupted blood supply to the heart due to a build-up of fatty substances in coronary arteries. Obstructive coronary artery diseases, non-obstructive artery diseases, and spontaneous coronary artery dissection are the major types of heart diseases that occur due to interrupted blood supply.
Growth in sedentary lifestyles, changes in eating habits, and increase in obesity are resulting in high prevalence of coronary heart diseases among adults and the geriatric population. Thus, rise in prevalence of coronary heart diseases among the geriatric population is driving the coronary artery bypass graft market revenue.
According to data published by the Journal of the American Heart Association in January 2023, more than 70% of people over 70 years of age are likely to develop cardiovascular diseases, and more than two-thirds would also have associated non-cardiovascular comorbidities. Thus, increase in geriatric population across the globe is driving the need for heart artery bypass, which in turn, is likely to spur the market dynamics.
Robot-assisted surgeries allow surgeons to perform complex procedures with more precision. These are minimally invasive surgeries that are less risky and have smaller surgical cuts. Minimally invasive coronary artery bypass graft surgery ensures fewer incisions, reduced hospitalization period, less blood loss, and high surgical accuracy. Thus, surgeons are increasingly preferring minimally invasive procedures to enhance accuracy and ensure patient safety.
Development of healthcare facilities in emerging countries is augmenting the availability of coronary artery disease surgical treatment, thereby fostering the coronary artery bypass graft market growth.
Public healthcare organizations and governments are investing significantly in the improvement of healthcare infrastructure to meet the surging demand for advanced treatments for coronary diseases. For instance, Million Hearts, a national initiative by the Department of Health & Human Services, aims to prevent one million heart attacks and strokes within five years. The Million Hearts Cardiac Rehabilitation Collaborative (CRC) is an open forum of multi-disciplinary professionals taking action to help at least 70% of eligible patients participate in cardiac rehabilitation.
As per the regional coronary artery bypass graft market analysis, North America dominated the global landscape in 2022. Increase in awareness about cardiovascular diseases and rise in access to advanced medical facilities are likely to propel the coronary artery bypass graft industry share of the region during the forecast period.
According to the Centers for Disease Control and Prevention, around 695,000 people in the U.S. died from heart disease in 2021. About 1 in 20 adults aged 20 and older has coronary artery disease, and around 375,476 fatalities were recorded in 2021 due to CAD. Increase in prevalence of strokes and coronary heart diseases is fueling the demand for coronary artery bypass graft in North America.
Companies operating in the global landscape are adopting the latest technologies to improve their product portfolio. They are investing substantially in the development of advanced products for usage in robotic surgeries. Leading coronary artery bypass graft market manufacturers are also conducting clinical trials to assess safety and efficacy of products.
Boston Scientific, Medtronic Plc, TERUMO CORPORATION, KARL STORZ GmbH & Co. KG, Sorin Group (LivaNova PLC), Ethicon US, LLC (Johnson & Johnson), NeoGraft Technologies, Inc., Edwards Lifesciences Corporation, MAQUET Holding B.V. & Co. KG, and Genesee Biomedical Inc. are the prominent players operating in the global landscape.
The coronary artery bypass graft market report scope covers these leading companies based on parameters such as company overview, business segments, product portfolio, recent developments, business strategies, and financial overview.
| Attribute | Detail |
|---|---|
| Market Size in 2022 | US$ 10.2 Bn |
| Market Forecast (Value) in 2031 | US$ 15.8 Bn |
| Growth Rate (CAGR) | 5.1% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Tons | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 10.2 Bn in 2022
It is projected to register a CAGR of 5.1% from 2023 to 2031
Rise in prevalence of coronary heart diseases and increase in demand for robotic surgeries
North America was the most lucrative region in 2022
Boston Scientific, Medtronic Plc, TERUMO CORPORATION, KARL STORZ GmbH & Co. KG, Sorin Group (LivaNova PLC), Ethicon US, LLC (Johnson & Johnson), NeoGraft Technologies, Inc., Edwards Lifesciences Corporation, MAQUET Holding B.V. & Co. KG, and Genesee Biomedical Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Coronary Artery Bypass Graft Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Coronary Artery Bypass Graft Market Analysis and Forecast, 2017-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Coronary Artery Bypass Graft Market Analysis and Forecast, by Product Type
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. On-pump CABG
6.3.2. Off-pump CABG
6.3.3. Minimally Invasive Direct CABG
6.3.4. Conventional CABG
6.4. Market Attractiveness, by Product Type
7. Global Coronary Artery Bypass Graft Market Analysis and Forecast, by Device
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Device, 2017–2031
7.3.1. Tissue Stabilizers
7.3.2. Heart Positioners
7.3.3. Refractors
7.3.4. Cannulas
7.3.5. Cardiopulmonary Bypass Machines
7.3.6. Endoscopic Vessel Harvesting Systems
7.3.7. Others
7.3.8. 7.4 Market Attractiveness, by Device
8. Global Coronary Artery Bypass Graft Market Analysis and Forecast, by Technique
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Technique, 2017–2031
8.3.1. Traditional Vessel Harvesting
8.3.2. Endoscopic Vessel Harvesting (EVH)
8.4. Market Attractiveness, by Technique
9. Global Coronary Artery Bypass Graft Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals
9.3.2. Cardiology Clinics
9.3.3. Research & Academic Institutions
9.4. Market Attractiveness, by End-user
10. Global Coronary Artery Bypass Graft Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017–2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Coronary Artery Bypass Graft Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. On-pump CABG
11.2.2. Off-pump CABG
11.2.3. Minimally Invasive Direct CABG
11.2.4. Conventional CABG
11.3. Market Attractiveness, by Product Type
11.4. Market Value Forecast, by Device, 2017–2031
11.4.1. Tissue Stabilizers
11.4.2. Heart Positioners
11.4.3. Refractors
11.4.4. Cannulas
11.4.5. Cardiopulmonary Bypass Machines
11.4.6. Endoscopic Vessel Harvesting Systems
11.4.7. Others
11.5. Market Attractiveness, by Device
11.6. Market Value Forecast, by Technique, 2017–2031
11.6.1. Traditional Vessel Harvesting
11.6.2. Endoscopic Vessel Harvesting (EVH)
11.7. Market Attractiveness, by Technique
11.8. Market Value Forecast, by End-user, 2017–2031
11.8.1. Hospitals
11.8.2. Cardiology Clinics
11.8.3. Research & Academic Institutions
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country/Sub-region, 2017–2031
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Product Type
11.11.2. By Device
11.11.3. By Technique
11.11.4. By End-user
11.11.5. By Country
12. Europe Coronary Artery Bypass Graft Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. On-pump CABG
12.2.2. Off-pump CABG
12.2.3. Minimally Invasive Direct CABG
12.2.4. Conventional CABG
12.3. Market Attractiveness, by Product Type
12.4. Market Value Forecast, by Device, 2017–2031
12.4.1. Tissue Stabilizers
12.4.2. Heart Positioners
12.4.3. Refractors
12.4.4. Cannulas
12.4.5. Cardiopulmonary Bypass Machines
12.4.6. Endoscopic Vessel Harvesting Systems
12.4.7. Others
12.5. Market Attractiveness, by Device
12.6. Market Value Forecast, by Technique, 2017–2031
12.6.1. Traditional Vessel Harvesting
12.6.2. Endoscopic Vessel Harvesting (EVH)
12.7. Market Attractiveness, by Technique
12.8. Market Value Forecast, by End-user, 2017–2031
12.8.1. Hospitals
12.8.2. Cardiology Clinics
12.8.3. Research & Academic Institutions
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2017–2031
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Product Type
12.11.2. By Device
12.11.3. By Technique
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific Coronary Artery Bypass Graft Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. On-pump CABG
13.2.2. Off-pump CABG
13.2.3. Minimally Invasive Direct CABG
13.2.4. Conventional CABG
13.3. Market Attractiveness, by Product Type
13.4. Market Value Forecast, by Device, 2017–2031
13.4.1. Tissue Stabilizers
13.4.2. Heart Positioners
13.4.3. Refractors
13.4.4. Cannulas
13.4.5. Cardiopulmonary Bypass Machines
13.4.6. Endoscopic Vessel Harvesting Systems
13.4.7. Others
13.5. Market Attractiveness, by Device
13.6. Market Value Forecast, by Technique, 2017–2031
13.6.1. Traditional Vessel Harvesting
13.6.2. Endoscopic Vessel Harvesting (EVH)
13.7. Market Attractiveness, by Technique
13.8. Market Value Forecast, by End-user, 2017–2031
13.8.1. Hospitals
13.8.2. Cardiology Clinics
13.8.3. Research & Academic Institutions
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2017–2031
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Product Type
13.11.2. By Device
13.11.3. By Technique
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America Coronary Artery Bypass Graft Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. On-pump CABG
14.2.2. Off-pump CABG
14.2.3. Minimally Invasive Direct CABG
14.2.4. Conventional CABG
14.3. Market Attractiveness, by Product Type
14.4. Market Value Forecast, by Device, 2017–2031
14.4.1. Tissue Stabilizers
14.4.2. Heart Positioners
14.4.3. Refractors
14.4.4. Cannulas
14.4.5. Cardiopulmonary Bypass Machines
14.4.6. Endoscopic Vessel Harvesting Systems
14.4.7. Others
14.5. Market Attractiveness, by Device
14.6. Market Value Forecast, by Technique, 2017–2031
14.6.1. Traditional Vessel Harvesting
14.6.2. Endoscopic Vessel Harvesting (EVH)
14.7. Market Attractiveness, by Technique
14.8. Market Value Forecast, by End-user, 2017–2031
14.8.1. Hospitals
14.8.2. Cardiology Clinics
14.8.3. Research & Academic Institutions
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2017–2031
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Product Type
14.11.2. By Device
14.11.3. By Technique
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa Coronary Artery Bypass Graft Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2017–2031
15.2.1. On-pump CABG
15.2.2. Off-pump CABG
15.2.3. Minimally Invasive Direct CABG
15.2.4. Conventional CABG
15.3. Market Attractiveness, by Product Type
15.4. Market Value Forecast, by Device, 2017–2031
15.4.1. Tissue Stabilizers
15.4.2. Heart Positioners
15.4.3. Refractors
15.4.4. Cannulas
15.4.5. Cardiopulmonary Bypass Machines
15.4.6. Endoscopic Vessel Harvesting Systems
15.4.7. Others
15.5. Market Attractiveness, by Device
15.6. Market Value Forecast, by Technique, 2017–2031
15.6.1. Traditional Vessel Harvesting
15.6.2. Endoscopic Vessel Harvesting (EVH)
15.7. Market Attractiveness, by Technique
15.8. Market Value Forecast, by End-user, 2017–2031
15.8.1. Hospitals
15.8.2. Cardiology Clinics
15.8.3. Research & Academic Institutions
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2017–2031
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Product Type
15.11.2. By Device
15.11.3. By Technique
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. Medtronic Plc
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. TERUMO CORPORATION
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. KARL STORZ GmbH & Co. KG
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Sorin Group (LivaNova PLC)
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Boston Scientific
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Ethicon US, LLC (Johnson & Johnson)
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. NeoGraft Technologies, Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Edwards Lifesciences Corporation
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. MAQUET Holding B.V. & Co. KG
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Genesee Biomedical Inc.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
List of Tables
Table 01: Global Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 02: Global Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Device, 2017–2031
Table 03: Global Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Technique, 2017–2031
Table 05: Global Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 06: North America Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 07: North America Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 08: North America Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Device, 2017–2031
Table 9: North America Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Technique, 2017–2031
Table 10: North America Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 11: Europe Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 12: Europe Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 13: Europe Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Device, 2017–2031
Table 14: Europe Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Technique, 2017–2031
Table 15: Europe Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Asia Pacific Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Asia Pacific Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 18: Asia Pacific Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Device, 2017–2031
Table 19: Asia Pacific Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Technique, 2017–2031
Table 20: Asia Pacific Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Latin America Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Latin America Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 23: Latin America Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Device, 2017–2031
Table 24: Latin America Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Technique, 2017–2031
Table 25: Latin America Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 26: Middle East & Africa Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 27: Middle East & Africa Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 28: Middle East & Africa Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Device, 2017–2031
Table 29: Middle East & Africa Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by Technique, 2017–2031
Table 30: Middle East & Africa Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Coronary Artery Bypass Graft Market Size (US$ Mn), by Region, 2022 and 2031
Figure 02: Global Coronary Artery Bypass Graft Market Revenue (US$ Mn), by Product Type, 2022
Figure 03: Global Coronary Artery Bypass Graft Market Value Share, by Product Type, 2022
Figure 04: Global Coronary Artery Bypass Graft Market Revenue (US$ Mn), by Device, 2022
Figure 05: Global Coronary Artery Bypass Graft Market Value Share, by Device, 2022
Figure 06: Global Coronary Artery Bypass Graft Market Revenue (US$ Mn), by Technique, 2022
Figure 07: Global Coronary Artery Bypass Graft Market Value Share, by Technique, 2022
Figure 08: Global Coronary Artery Bypass Graft Market Revenue (US$ Mn), by End-user, 2022
Figure 09: Global Coronary Artery Bypass Graft Market Value Share, by End-user, 2022
Figure 10: Global Coronary Artery Bypass Graft Market Value Share, by Region, 2022
Figure 11: Global Coronary Artery Bypass Graft Market Value (US$ Mn) Forecast, 2017–2031
Figure 12: Global Coronary Artery Bypass Graft Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 13: Global Coronary Artery Bypass Graft Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 14: Global Coronary Artery Bypass Graft Market Value Share Analysis, by Device, 2022 and 2031
Figure 15: Global Coronary Artery Bypass Graft Market Attractiveness Analysis, by Device, 2023-2031
Figure 16: Global Coronary Artery Bypass Graft Market Value Share Analysis, by Technique, 2022 and 2031
Figure 17: Global Coronary Artery Bypass Graft Market Attractiveness Analysis, by Technique, 2023-2031
Figure 18: Global Coronary Artery Bypass Graft Market Revenue (US$ Mn), by End-user, 2022
Figure 19: Global Coronary Artery Bypass Graft Market Value Share, by End-user, 2022
Figure 20: Global Coronary Artery Bypass Graft Market Value Share Analysis, by Region, 2022 and 2031
Figure 21: Global Coronary Artery Bypass Graft Market Attractiveness Analysis, by Region, 2023-2031
Figure 22: North America Coronary Artery Bypass Graft Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 23: North America Coronary Artery Bypass Graft Market Attractiveness Analysis, by Country, 2023–2031
Figure 24: North America Coronary Artery Bypass Graft Market Value Share Analysis, by Country, 2022 and 2031
Figure 25: North America Coronary Artery Bypass Graft Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 26: North America Coronary Artery Bypass Graft Market Value Share Analysis, by Device, 2022 and 2031
Figure 27: North America Coronary Artery Bypass Graft Market Value Share Analysis, by Technique, 2022 and 2031
Figure 28: North America Coronary Artery Bypass Graft Market Value Share Analysis, by End-user, 2022 and 2031
Figure 29: North America Coronary Artery Bypass Graft Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 30: North America Coronary Artery Bypass Graft Market Attractiveness Analysis, by Device, 2023–2031
Figure 31: North America Coronary Artery Bypass Graft Market Attractiveness Analysis, by Technique, 2023–2031
Figure 32: North America Coronary Artery Bypass Graft Market Attractiveness Analysis, by End-user, 2023–2031
Figure 33: Europe Coronary Artery Bypass Graft Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 34: Europe Coronary Artery Bypass Graft Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 35: Europe Coronary Artery Bypass Graft Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 36: Europe Coronary Artery Bypass Graft Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 37: Europe Coronary Artery Bypass Graft Market Value Share Analysis, by Device, 2022 and 2031
Figure 38: Europe Coronary Artery Bypass Graft Market Value Share Analysis, by Technique, 2022 and 2031
Figure 39: Europe Coronary Artery Bypass Graft Market Value Share Analysis, by End-user, 2022 and 2031
Figure 40: Europe Coronary Artery Bypass Graft Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 41: Europe Coronary Artery Bypass Graft Market Attractiveness Analysis, by Device, 2023–2031
Figure 42: Europe Coronary Artery Bypass Graft Market Attractiveness Analysis, by Technique, 2023–2031
Figure 43: Europe Coronary Artery Bypass Graft Market Attractiveness Analysis, by End-user, 2023–2031
Figure 44: Asia Pacific Coronary Artery Bypass Graft Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 45: Asia Pacific Coronary Artery Bypass Graft Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 46: Asia Pacific Coronary Artery Bypass Graft Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 47: Asia Pacific Coronary Artery Bypass Graft Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 48: Asia Pacific Coronary Artery Bypass Graft Market Value Share Analysis, by Device, 2022 and 2031
Figure 49: Asia Pacific Coronary Artery Bypass Graft Market Value Share Analysis, by Technique, 2022 and 2031
Figure 50: Asia Pacific Coronary Artery Bypass Graft Market Value Share Analysis, by End-user, 2022 and 2031
Figure 51: Asia Pacific Coronary Artery Bypass Graft Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 52: Asia Pacific Coronary Artery Bypass Graft Market Attractiveness Analysis, by Device, 2023–2031
Figure 53: Asia Pacific Coronary Artery Bypass Graft Market Attractiveness Analysis, by Technique, 2023–2031
Figure 54: Asia Pacific Coronary Artery Bypass Graft Market Attractiveness Analysis, by End-user, 2022–2031
Figure 55: Latin America Coronary Artery Bypass Graft Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 56: Latin America Coronary Artery Bypass Graft Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 57: Latin America Coronary Artery Bypass Graft Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 58: Latin America Coronary Artery Bypass Graft Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 59: Latin America Coronary Artery Bypass Graft Market Value Share Analysis, by Device, 2022 and 2031
Figure 60: Latin America Coronary Artery Bypass Graft Market Value Share Analysis, by Technique, 2022 and 2031
Figure 61: Latin America Coronary Artery Bypass Graft Market Value Share Analysis, by End-user, 2022 and 2031
Figure 62: Latin America Coronary Artery Bypass Graft Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 63: Latin America Coronary Artery Bypass Graft Market Attractiveness Analysis, by Device, 2023–2031
Figure 64: Latin America Coronary Artery Bypass Graft Market Attractiveness Analysis, by Technique, 2023–2031
Figure 65: Latin America Coronary Artery Bypass Graft Market Attractiveness Analysis, by End-user, 2023–2031
Figure 66: Middle East & Africa Coronary Artery Bypass Graft Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 67: Middle East & Africa Coronary Artery Bypass Graft Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 68: Middle East & Africa Coronary Artery Bypass Graft Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 69: Middle East & Africa Coronary Artery Bypass Graft Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 70: Middle East & Africa Coronary Artery Bypass Graft Market Value Share Analysis, by Device, 2022 and 2031
Figure 71: Middle East & Africa Coronary Artery Bypass Graft Market Value Share Analysis, by Technique, 2022 and 2031
Figure 72: Middle East & Africa Coronary Artery Bypass Graft Market Value Share Analysis, by End-user, 2022 and 2031
Figure 73: Middle East & Africa Coronary Artery Bypass Graft Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 74: Middle East & Africa Coronary Artery Bypass Graft Market Attractiveness Analysis, by Device, 2023–2031
Figure 75: Middle East & Africa Coronary Artery Bypass Graft Market Attractiveness Analysis, by Technique, 2023–2031
Figure 76: Middle East & Africa Coronary Artery Bypass Graft Market Attractiveness Analysis, by End-user, 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Coronary Artery Bypass Graft Market